Author | Year | The country of the subject | Prospective | Age | BMI (kg/m2) | Time interval | Subject population | CRF | Patients (M/F) | Imaging device |
---|---|---|---|---|---|---|---|---|---|---|
Lu [9] | 2022 | Austria a | N | 68 ± 10 | 27.1 | 1 W | Lymphoma | Smoking, Hypertension, Dyslipidemia, Diabetes, CRP(≥ 3 mg/L) | 19(11/8) | PET/ MRI |
Lawal [10] | 2020 | SouthAfrica | Y | 44.67 ± 7.62 | 24.18 ± 3.45 | 2 D | HIV-infected | Smoking, Hypertension, Diabetes, Family history of CVD | 12(4/8) | PET/ CT |
Kircher [11] | 2020 | Germany | N | 62 ± 10 | 26 | 3 D | Multiple Myeloma Adrenocortical Cancer Neuroendocrine Tumour Non-Small Cell Lung Cancer Pleuramesothelioma Lymphoma Stomach Cancer Hepatocellulary-Carcinoma T-Cell Non-Hodgkin Lymphoma Small Cell Lung Cancer Pancreatic Cancer Thyroid Cancer Diffuse Large B-cell Lymphoma | Smoking, Hypertension, Diabetes, CRP(≥ 3 mg/L), Obesity, History of CVD | 92(55/37) | PET/ CT |
Li [12] | 2019 | Austria China | Y | 61.8 ± 12.7 | 26.8 ± 4.0 | NR | Mucosa-associated lymphoid tissue (MALT) lymphoma | Smoking, Hypertension, Dyslipidemia, Diabetes | 72(45/27) | PET/ MRI |
Li [13] | 2018 | NR | Y | 67 ± 11 | 26 ± 4 | 3 W | Lymphoma Pancreatic cancer | Smoking, Hypertension, Dyslipidemia, Diabetes, Family history of CVD, History of CVD | 34(17/17) | PET/ MRI |
Weiberg [14] | 2018 | Germany | N | 59.5 ± 16.2 | NR | NR | Interstitial lung disease Sarcoidosis Complicated urinary tract infection Leukemia Miscellaneous | Smoking, Hypertension, Dyslipidemia, Diabetes, History of CVD | 51(39/12) | PET/ CT |